Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Noninferiority of OS with 3 Months Compared to 6 Months of...

Ogkologos - 20 Ιανουαρίου, 2026

Patient Guide on Bone Health in Cancer Now Available Also in French

Ogkologos - 19 Ιανουαρίου, 2026

Lung Cancer Death Rates Among Women in Europe Are Finally Levelling...

Ogkologos - 19 Ιανουαρίου, 2026

A Combination of Savolitinib and Osimertinib Prolongs PFS in Patients with...

Ogkologos - 16 Ιανουαρίου, 2026

EMA Recommends Granting a Conditional Marketing Authorisation for Nogapendekin alfa Inbakicept

Ogkologos - 15 Ιανουαρίου, 2026

Patient Guide in Testicular Cancer Now Available Also in German

Ogkologos - 14 Ιανουαρίου, 2026

FDA Approves Amivantamab and Hyaluronidase-lpuj for Subcutaneous Injection

Ogkologos - 14 Ιανουαρίου, 2026

AI Model Identifies How Every Country Can Improve Its Cancer Outcomes

Ogkologos - 14 Ιανουαρίου, 2026

A Combination of Teclistamab and Daratumumab Prolongs PFS in Patients with...

Ogkologos - 12 Ιανουαρίου, 2026

Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with...

Ogkologos - 9 Ιανουαρίου, 2026

1...282930...440 Σελίδα 29 από 440

MOST POPULAR

Frederick National Laboratory for Cancer Research: A Unique Resource for the...

28 Μαρτίου, 2023

Low-Pass Genomic Instability Characterisation Assay Identifies Germline Mismatch Repair Deficiency and...

20 Οκτωβρίου, 2022

Study Adds to Debate about Mammography in Older Women

12 Σεπτεμβρίου, 2023

The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights...

22 Δεκεμβρίου, 2025

Φόρτωση περισσοτέρων

Noninferiority of OS with 3 Months Compared to 6 Months of...

Patient Guide on Bone Health in Cancer Now Available Also in French

Lung Cancer Death Rates Among Women in Europe Are Finally Levelling...

A Combination of Savolitinib and Osimertinib Prolongs PFS in Patients with...

EMA Recommends Granting a Conditional Marketing Authorisation for Nogapendekin alfa Inbakicept

Patient Guide in Testicular Cancer Now Available Also in German

FDA Approves Amivantamab and Hyaluronidase-lpuj for Subcutaneous Injection

AI Model Identifies How Every Country Can Improve Its Cancer Outcomes

A Combination of Teclistamab and Daratumumab Prolongs PFS in Patients with...

Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with...

MOST POPULAR

Frederick National Laboratory for Cancer Research: A Unique Resource for the...

Low-Pass Genomic Instability Characterisation Assay Identifies Germline Mismatch Repair Deficiency and...

Study Adds to Debate about Mammography in Older Women

The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights...

HOT NEWS

Pelabresib Plus Ruxolitinib Improves Signs of Underlying Myelofibrosis Pathobiology and Provides...

Addressing Mental Health Needs of Adolescent and Young Adult Cancer Survivors

FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection

How Joining a Clinical Trial Helped Me Find Hope While Living...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ